Blog

1 May 2024 - The May 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

8 April 2024 - Australians with high cholesterol, chronic kidney disease and ovarian cancer now have access to cheaper medicines under ...

1 April 2024 - Starting this month, Sotyktu (deucravacitinib), an oral treatment for moderate to severe plaque psoriasis in adults, ...

1 April 2024 - The April 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

1 April 2024 - The April 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

27 March 2024 - PHARMAC is funding two new cancer treatments, one for advanced breast cancer (ribociclib succinate) and one ...

1 March 2024 - The March 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

3 January 2024 - Pfizer's second generation targeted therapy for chronic myeloid leukaemia, Bosulif (bosutinib), has been newly registered with ...

1 February 2024 - The February 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

1 February 2024 - The February 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

23 January 2024 - This week, we have reviewed the listing of innovative (patent protected) health care technologies in the ...

21 January 2024 - Treatment for advanced melanoma is set to become cheaper under the Pharmaceutical Benefits Scheme in the ...

18 January 2024 - In contrast to New Zealand, 2023 saw many new medicines listed on the PBS. ...

17 January 2024 - 2023 was yet another dismal year for New Zealanders in terms of them being able to ...